“Our goal is to accelerate the Botanical Synthesis movement that our team has wholly dedicated themselves to – driving forward innovation, our...
Read MoreUNPRECEDENTED BIOHARVEST MEDIA COVERAGE! Plus a request from CEO Ilan Sobel
Dear subscriber,
This has been an epic week for BioHarvest Sciences Inc., highlighted by our Dec 8 announcement that we have produced over 10kg of high-density trichome/cannabis biomass WITHOUT GROWING THE PLANT. This news has caused a groundswell of media and investor attention, and we want to keep you “up-to-speed” on all the action. How productive has this past week been? Our last newsletter was sent on November 30, and these are the new activities that have happened in the past 10 days! Plenty more to come in December, so stay tuned!
Special Request from Ilan Sobel to our BHSC community
Links to “Cannabis Without the Plant – History in the Making” on Social media: Youtube Twitter Facebook LinkedIn
Dec 8-9 Media highlights
Our public relations teams at Boldt and Thunder11 have been actively introducing the BioHarvest story to journalists, and we are building serious momentum in both the cannabis industry and mainstream media. The following are some coverage highlights from just the past 2 days!
“Producing Cannabis Biomass Without Growing A Cannabis Plant: How One Company is Doing It”. Being covered by Forbes.com is a powerful validation that history is truly being made by our R+D team. The article states that our ability to grow cannabis without the plant “Sounds like something out of a science fiction movie, but it’s very real.” Read Article
THE cannabis magazine shared our Biomass video with their 2.7 Million followers on Dec 9. One day later, their followers have now watched it over 40,000x, and it has 3200+ “likes”. As we become a more prominent member of the cannabis community, we look forward to educating the established cannabis ecosystem on the unique benefits of our products.
CannabisFN.com
posted an article on our Biomass release and shared on social media. Their Twitter feed alone has generated more than 20,000 views of the video since Tuesday morning.
On December 8, Ilan presented at the Global Cannabis Summit, an industry conference for leaders in cannabis cultivation, products, science, and investment. We updated our corporate deck to correspond with this event, and you are invited to download the new presentation deck.
New Frontiers
On December 1, we were thrilled to announce that Chris Hadfield, former Commander of the International Space Station, has joined the BioHarvest Sciences Advisory Board. Colonel Hadfield’s mandate is twofold – to act as a technology advisor, and to work with the BioHarvest team on ways to leverage our biotech technology platform to provide essential nutrition and active ingredients for space exploration and potential new
settlements in space. If you have not seen Commander Hadfield’s videos from the space station, look them up on Youtube, as they are amazing!
New to BioHarvest?
All interested investors and media are invited to attend our next “Introduction to BioHarvest” online event on Dec 21. CEO Ilan Sobel will provide an investor-focused introduction to our Science and our Vision, and we will include a live question and answer session. Register now!
Our Blog
Are depleted soils depleting the benefits of fruits and vegetables?
By Dr. Brian Cornblatt Over the past 50 years there has been a paradigm shift in dietary preferences. The proverbial meat and potatoes —once...
Read MoreAbout BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals – nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API’s) that focus on specific medical indications.